AKS News Alert AK Steel Holding Corp (AKS) 6.32 11/13/2014 1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
AK Steel Holding Corp (AKS) 6.32 $AKS

AK Steel (AKS) Reaches New Labor Agreement with USW - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 6:09PM CST
AK Steel (AKS) has announced the ratification of a new three-year labor agreement by the members of USW Local 1915.
STLD: 22.34 (-0.07), NUE: 53.36 (+0.09), AKS: 6.32 (+0.08), X: 35.25 (+0.47)

Insider Trading Alert - TSLA, COV And AKS Traded By Insiders
at The Street - Tue Nov 11, 9:08AM CST
Stocks with insider trader activity include TSLA, COV and AKS
TSLA: 251.70 (+2.60), COV: 93.67 (+0.79), AKS: 6.32 (+0.08)

Watch for Shares of AK Steel Holding (AKS) to Approach Support at $6.33
Comtex SmarTrend(R) - Tue Nov 11, 8:59AM CST
Shares of AK Steel Holding (NYSE:AKS) opened today below their pivot of $6.67 and have already reached the first level of support at $6.48. Analysts will be watching for a cross of the next downside pivot targets of $6.33 and $5.99.
AKS: 6.32 (+0.08)

Insider Trading Recap for AK Steel, Pfizer, Chesapeake Energy, Plug Power, Twitter, and RF Micro Devices
PR Newswire - Tue Nov 11, 7:45AM CST
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: AK Steel (NYSE:AKS), Pfizer (NYSE FE), Chesapeake Energy (NYSE:CHK), Plug Power (NASDAQ LUG), Twitter (NYSE:TWTR), and RF Micro Devices (NASDAQ:RFMD).
PLUG: 4.06 (-0.18), CHK: 22.71 (-0.70), PFE: 30.42 (unch), AKS: 6.32 (+0.08), TWTR: 40.04 (-2.50), RFMD: 13.33 (+0.08)

AK Steel (AKS) Up on Winning NOES Trade Cases - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 2:04PM CST
AK Steel's (AKS) shares climbed after the ITC reached a positive decision that imposed antidumping orders on six nations.
STLD: 22.34 (-0.07), NUE: 53.36 (+0.09), AKS: 6.32 (+0.08), X: 35.25 (+0.47)

Insider Trading Alert - NDLS, EL And AKS Traded By Insiders
at The Street - Mon Nov 10, 9:07AM CST
Stocks with insider trader activity include NDLS, EL and AKS
NDLS: 23.47 (-0.67), AKS: 6.32 (+0.08), EL: 72.55 (-0.07)

USW Members Ratify New Labor Agreement at AK Steel Tubemaking Unit
PR Newswire - Mon Nov 10, 7:45AM CST
AK Steel (NYSE: AKS) said today that members of United Steelworkers of America (USW) Local 1915 have ratified a new three-year labor agreement with its wholly-owned subsidiary, AK Tube LLC, covering about 100 hourly production and maintenance employees at its Walbridge, Ohio facility.
AKS: 6.32 (+0.08)

InsiderInsights.com Daily Round Up 11/7/14: AKS, ENH, SCCO, ERII
InsiderInsights - at Seeking Alpha - Sun Nov 09, 1:24AM CST

SCCO: 29.39 (-0.61), WWWW: 16.29 (+0.28), HA: 18.12 (-0.09), ARI: 16.45 (-0.05), BBY: 35.49 (+0.29), AKS: 6.32 (+0.08), BMY: 57.80 (-0.81), CDW: 32.57 (+0.10), HT: 7.40 (+0.02), K: 63.80 (+0.12), SPW: 91.83 (-0.79), STAA: 8.86 (-0.01), NDLS: 23.47 (-0.67), SIX: 40.53 (-0.34), BAGL: 20.23 (-0.01), MDAS: 20.72 (+0.16), ENH: 57.77 (-0.03), SCHW: 28.79 (+0.01), ERII: 4.69 (-0.14)

'Fast Money' Recap: When Is the Best Time to Buy Twitter Stock?
at The Street - Sat Nov 08, 4:00AM CST
The trading panel discussed whether it would help or hurt Twitter if its CEO steps down and whether Coca-Cola has any fizz left in it.
KO: 42.79 (+0.08), YHOO: 50.50 (-0.10), MNST: 108.16 (+0.25), ANF: 28.90 (-0.45), SLXP: 96.99 (+1.44), FFIV: 126.15 (+0.39), AKS: 6.32 (+0.08), TWTR: 40.04 (-2.50), GDX: 17.94 (-0.30), FXF: 101.32 (+0.34)

Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data
at The Street - Fri Nov 07, 3:22PM CST
The Dow Jones Industrial Average posts a small gain in the final minutes to closing bell, just enough to cement the index's third consecutive record close.
MNST: 108.16 (+0.25), FSLR: 47.56 (-2.03), SLXP: 96.99 (+1.44), AKS: 6.32 (+0.08), SHLD: 37.80 (+0.04), VSAT: 67.23 (+3.22)

AK Steel CEO discloses purchase of 160K shares
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 1:17PM CST

AKS: 6.32 (+0.08)

AK Steel (AKS) Stock Rises After Positive Trade Commission Decision
at The Street - Fri Nov 07, 9:27AM CST
AK Steel (AKS) shares are climbing after the company announced that the ITC ruled in its favor and imposed antidumping duties against six importing countries.
AKS: 6.32 (+0.08)

AK Steel wins trade cases on non-oriented electrical steel
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 3:55PM CST

AKS: 6.32 (+0.08)

AK Steel Wins Trade Cases on Non-Oriented Electrical Steel
PR Newswire - Thu Nov 06, 3:40PM CST
AK Steel (NYSE: AKS) said today the U.S. International Trade Commission (ITC) reached an affirmative (4-1) final determination that the domestic industry producing non-oriented electrical steel (NOES) is materially injured by reason of dumped and subsidized imports from six countries. The final injury determination means that antidumping orders will be imposed against imports from all six countries and countervailing duty orders will be imposed against imports from China and Taiwan.
AKS: 6.32 (+0.08)

Most active New York Stock Exchange-traded stocks
AP - Thu Nov 06, 12:17PM CST
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:
KO: 42.79 (+0.08), F: 14.93 (+0.35), GE: 26.42 (-0.10), RF: 10.17 (-0.04), ABX.TO: 13.11 (-0.14), K.TO: 2.87 (+0.08), ABX: 11.51 (-0.22), AKS: 6.32 (+0.08), BAC: 17.22 (-0.07), ANR: 2.42 (-0.20), GNW: 9.30 (+0.50), YRI.TO: 4.13 (-0.15), S: 5.00 (unch), KGC: 2.52 (+0.06), TWTR: 40.04 (-2.50), AUY: 3.64 (-0.13), AM: 28.65 (-0.35)

Next Support Level for AK Steel Holding (AKS) is $5.91
Comtex SmarTrend(R) - Thu Nov 06, 11:39AM CST
Shares of AK Steel Holding (NYSE:AKS) have bearishly opened below the pivot of $6.25 today and have reached the first support level of $6.06. Analysts will be watching for a cross of the next downside pivot targets of $5.91 and $5.57.
AKS: 6.32 (+0.08)

'Mad Money' Lightning Round: Pull the Trigger on Baxter
at The Street - Thu Nov 06, 5:00AM CST
Cramer likes Illumina but isn't a big fan of GEO Group or AK Steel Holdings.
RIG: 26.29 (-0.79), GEO: 39.69 (-0.30), TMO: 118.24 (-0.27), ESV: 38.76 (-0.51), NUE: 53.36 (+0.09), BAX: 72.08 (+0.75), ILMN: 185.00 (-1.92), AKS: 6.32 (+0.08), OXY: 86.29 (-2.30)

Cramer's Lightning Round - Baxter May Go Faster (11/5/14)
SA Editor Miriam Metzinger - Seeking Alpha - Thu Nov 06, 4:59AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday November 5. Bullish Calls: Baxter (NYSE: BAX ): "I think it is finally starting to run. It has lagged, but it is time to pull the...
RIG: 26.29 (-0.79), GEO: 39.69 (-0.30), TMO: 118.24 (-0.27), NUE: 53.36 (+0.09), BAX: 72.08 (+0.75), ILMN: 185.00 (-1.92), AKS: 6.32 (+0.08), OXY: 86.29 (-2.30)

Jim Cramer's 'Mad Money' Recap: What a Republican Senate Means for Stocks
at The Street - Wed Nov 05, 7:20PM CST
It's bullish news but you can't buy just anything, Cramer says.
ACT: 241.63 (+1.01), LMT: 187.97 (+1.10), XOM: 94.66 (-0.72), ILMN: 185.00 (-1.92), AKS: 6.32 (+0.08), KORS: 70.74 (-0.26), PAYX: 47.43 (-0.06), RIG: 26.29 (-0.79), EOG: 95.85 (-1.71), COST: 138.71 (+1.81), TWTR: 40.04 (-2.50), OXY: 86.29 (-2.30), KO: 42.79 (+0.08), SEAS: 17.02 (+0.17), TMO: 118.24 (-0.27), NUE: 53.36 (+0.09), TRIP: 69.02 (-1.36), DISCA: 32.86 (+1.00), CHUY: 22.25 (-0.24), LB: 77.05 (-0.89), GEO: 39.69 (-0.30), ESV: 38.76 (-0.51), MPC: 93.55 (-1.46), BAX: 72.08 (+0.75), MRK: 59.54 (+0.23), EXPE: 86.49 (-0.62), STI: 39.78 (-0.07)

AK Steel's Q3 Earnings Top, Shares Sag on Outage Concern - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:50AM CST
AK Steel (AKS) saw its losses narrow in the third quarter and its results topped expectations.
STLD: 22.34 (-0.07), NUE: 53.36 (+0.09), AKS: 6.32 (+0.08), X: 35.25 (+0.47)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 185

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 176

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 221

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 79

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 207

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Opportunities in Oversold Tech Stocks Today

Updated Category News Views 121

Market Dynamics and Oversold Stocks Recently, we witnessed a notable sell-off in the stock market, which was fueled by rising concerns surrounding the AI industry. As a result, many stocks experienced a significant pullback. Interestingly, this downturn did not discriminate and impacted various equities, including those unrelated to the AI sector. It's essential to...

Continue Reading
Innovative Device Revolutionizes Leg Recovery Process

Updated Category News Views 109

A Breakthrough in Leg Recovery: The LEG LIFTER Recovering from an injury or surgery can be a challenging process, especially when it comes to managing mobility. An inventive entrepreneur has come up with a unique solution to assist those dealing with leg injuries. The designer, based in Marietta, has developed the LEG LIFTER, a tool aimed at facilitating the lifting and...

Continue Reading
Vizsla Silver's New Strategic Acquisition Enhances Panuco Project

Updated Category News Views 78

Vizsla Silver Expands its Footprint with Key Acquisition In an exciting development, Vizsla Silver Corp. (NYSE: VZLA) (TSX: VZLA) has entered into an agreement to acquire significant claims that will bolster its already promising Panuco project. Ten new claims totaling 2,378 hectares have been purchased from Minera Fresnillo S.A. de C.V., a Fresnillo plc subsidiary. This...

Continue Reading
C3.ai Investors Seek Justice Amid Recent Stock Concerns

Updated Category News Views 91

Understanding the Situation for C3.ai Investors C3.ai, Inc. (NYSE: AI) has recently made headlines, not for positive advancements, but due to significant concerns regarding its stock performance and allegations of misleading statements. Shareholders who purchased shares during a specific class period might have encountered substantial losses, prompting the need for...

Continue Reading
Class Action Alert for Investors of Regeneron Pharmaceuticals

Updated Category News Views 139

Investors of Regeneron Pharmaceuticals Urged to Act In the bustling world of biotechnology, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has captured significant attention. Recently, the exceptionally reputable Rosen Law Firm announced a class action lawsuit, bringing notice to shareholders who have purchased securities from November 2, 2023, to October 30, 2024. This...

Continue Reading